Neonatal Onset Seizures and Hypotonia Due to D-Bifunctional Protein Deficiency

Sohier Yahia1, Dina Ghozzy1, Yahya Wahba1

  • 1Department of Pediatrics, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

PubMed

Insights

Medium-chain triglyceride (MCT) formula shows promise for treating D-bifunctional protein deficiency, a rare inherited peroxisomal disorder. This intervention helped manage seizures and improve symptoms in an infant case.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Peroxisomal disorders (PDs) are inherited conditions affecting peroxisomal function.
  • D-bifunctional protein (DBP) deficiency, a type of PD, is linked to HSD17B4 gene mutations and presents as Zellweger-like syndrome.
  • Confirmed cases of DBP deficiency are rare.

Purpose of the Study:

  • To report a case of D-bifunctional protein deficiency in an infant.
  • To investigate the therapeutic potential of medium-chain triglyceride (MCT) formula in managing DBP deficiency symptoms.

Main Methods:

  • Clinical presentation analysis of a 6-month-old female infant with neonatal-onset symptoms.
  • Biochemical analysis including acylcarnitine profile to detect elevated very long-chain fatty acids.
  • Genetic analysis using whole exome sequencing to identify mutations in the HSD17B4 gene.
  • Therapeutic intervention with MCT formula and assessment of its effects.

Main Results:

  • The infant presented with intractable seizures, hypotonia, facial dysmorphia, and hepatomegaly.
  • Acylcarnitine profile indicated elevated very long-chain fatty acids.
  • Whole exome sequencing revealed a homozygous missense mutation (c.1444A>T) in the HSD17B4 gene.
  • MCT formula administration resulted in seizure control, improved muscle tone, and reduced liver size.

Conclusions:

  • This case highlights a potential therapeutic role for MCT-containing formulas in managing D-bifunctional protein deficiency.
  • Early diagnosis and intervention with specialized formulas may improve clinical outcomes in patients with DBP deficiency.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
121
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
646
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
297
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
174
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K